Loading...
Use of four‐factor prothrombin complex concentrate for the mitigation of rivaroxaban‐induced bleeding in an emergent coronary artery bypass graft
We presented the first case of four‐factor prothrombin complex concentrate (4F‐PCC) for the alleviation of bleeding for emergent on‐pump coronary artery bypass graft (CABG) with the patient discharged by postoperative day (POD) 9 with no sequelae. Until direct antidotes are available, 4F‐PCC may pla...
Na minha lista:
| Udgivet i: | Clin Case Rep |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5412829/ https://ncbi.nlm.nih.gov/pubmed/28469866 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.790 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|